Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay

By sjmartinez • January 31, 2025

Kaur I, Shaw B, Multani A, Pham C, Malhotra S, Smith E, Adachi K, Allyn P, Bango Z, Beaird OE, Caldera JR, Chandrasekaran S, Chan L, Cheema R, Daouk S, Deville J, Dong HV, Fan A, Garner O, Gaynor P, Gray H, Gorin A, Kalava S, Kanatani M, Karnaze A, Saleh T, Sharma Y, Stauber S, Vargas M, Veral M, Winston D, Yanagimoto-Ogawa L, Aldrovandi G, Nielsen-Saines K, Fuller T, Jackson N, Uslan D, Schaenman J, Vijayan T, Sakona A, Yang S. Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay. Infect Control Hosp Epidemiol. 2025 Jan 30:1-8. doi: 10.1017/ice.2024.242. Epub ahead of print. PMID: 39881594.

Tags: DOM STAT, Fellow, General Internal Medicine, Infectious Diseases, preventive medicine

William J. Carroll, MD, FACP Appointed Section Chief of Palliative Care and Extensivist Medicine

The UCLA Department of Medicine (DoM) is pleased to announce the appointment of William J. Carroll, MD, FACPas section chief of the UCLA DoM Palliative Care[...]

Joshua N. Khalili, MD Appointed to DoM Chief Wellness Officer

The UCLA Department of Medicine has appointed Joshua N. Khalili, MD to chief wellness officer (CWO) effective April 1. The appointment builds on Dr. Khalili’s outstanding work[...]

Sun M. Yoo, MD, MPH to Depart DoM to Pursue New Leadership Opportunity

The UCLA Department of Medicine (DoM) announces that Sun M. Yoo, MD, MPH, will be departing UCLA Health to assume the role of a founding chief[...]